GILEAD SCIENCES, INC. (GILD)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, GILEAD SCIENCES, INC. reported revenue of $29.44B, up 2.4% from the prior year. The company was profitable, with a net margin of 28.9%.
Key ratios (FY2025)
34.0%
Operating margin
28.9%
Net margin
37.6%
Return on equity
+2.4%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.44B | $28.75B | $27.12B | $27.28B | $27.30B | $24.69B | $22.45B | $22.13B | $26.11B | $30.39B |
| Cost of Revenue | $6.23B | $6.25B | $6.50B | $5.66B | $6.60B | $4.57B | $4.67B | $4.85B | $4.37B | $4.26B |
| Operating Income | $10.02B | $1.66B | $7.61B | $7.33B | $9.92B | $4.07B | $4.29B | $8.20B | $14.12B | $17.63B |
| Net Income | $8.51B | $480.00M | $5.67B | $4.59B | $6.22B | $123.00M | $5.39B | $5.46B | $4.63B | $13.50B |
| EPS (Diluted) | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 |
| Total Assets | $59.02B | $58.99B | $62.12B | $63.17B | $67.95B | $68.41B | $61.63B | $63.67B | $70.28B | $56.98B |
| Shareholders' Equity | $22.62B | $19.25B | $22.75B | $21.21B | $21.06B | $18.22B | $22.65B | $21.53B | $20.50B | $19.36B |
| Cash & Equivalents | — | — | — | $5.41B | $5.34B | $6.00B | $11.63B | $17.94B | $7.59B | $8.23B |
| Operating Cash Flow | $10.02B | $10.83B | $8.01B | $9.07B | $11.38B | $8.17B | $9.14B | $8.40B | $11.90B | $17.05B |
| Capital Expenditures | $563.00M | $523.00M | $585.00M | $728.00M | $579.00M | $650.00M | $825.00M | $924.00M | — | — |
| Shares Outstanding | 1.25B | 1.25B | 1.26B | 1.26B | 1.26B | 1.26B | 1.28B | 1.31B | 1.32B | 1.36B |
| Dividends Per Share | $3.16 | $3.08 | $3.00 | $2.92 | $2.84 | $2.72 | $2.52 | $2.28 | $2.08 | $1.84 |